Şiddetli baş ağrısı ile başvuran hipertansif hastada beklenmedik bir olgu: herpes zoster oftalmikus vakası

Year 2023, Volume: 4 Issue: 3, 98 - 100, 30.09.2023

İbrahim Noyın , Ozan Altaç , Ömer İlbey Temiz , Özge Kurtkulağı , Fatih Kamış

https://doi.org/10.55665/troiamedj.1295158

Abstract

Varicella Zoster Virüs primer enfeksiyondan sonra nöronlarda latent olarak kalır ve özellikle immunsupresyon, travma, stres gibi durumlarda reaktive olabilir. Bu olguda ilk başvurusunda baş ağrısı şikayeti ile başvuran, hipertansif olması sebebi ile hospitalize edilen bir hasta ele alınmıştır. Medikal tedavisi düzenlendikten sonra hala baş ağrısı devam eden hastada devam eden süreçte herpetik döküntüler gelişmiştir ve herpes zoster oftalmicus tanısı konulmuştur. Tartışılan olguda olduğu gibi risk faktörleri olmayan hastalarda dahi herpes zoster oftalmicus gelişebileceği vurgulanmıştır.

Keywords

Varicella, başağrısı, skalp

An unexpected case in a hypertensive patient presenting with severe headache: a case of herpes zoster ophthalmicus

Abstract

Varicella Zoster Virus remains latent in neurons after primary infection and can be reactivated especially in conditions such as immunosuppression, trauma, and stress. In this case, a patient who applied with the complaint of headache in his first application and was hospitalized because of hypertensive is discussed. Herpetic eruptions developed in the ongoing process in the patient whose headache still continued after medical treatment was arranged and the diagnosis of herpes zoster ophthalmicus was made. As in the case discussed, it was emphasized that herpes zoster ophthalmicus may develop even in patients without risk factors.

Keywords

Varicella, headache, scalp

References

• 1. Topçu W. A., Söyletir G. ve Doğanay M. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 4.baskı. Nobel Tıp Kitabevleri. 2017: 1474-1478.
• 2. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 Suppl):S3-12.
• 3. Marra F., Chong M. and Najafzadeh M. Increasing inci-dence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis. 2016; 16: 589.
• 4. Schmader K. Herpes zoster. Clin Geriatr Med. 2016; 32: 539–353.
• 5. Marin M., et al. Risk factors for herpes zoster among adults. Open Forum Infect Dis. 2016; 3:119.
• 6. Arvin A. Aging, immunity and the varicella zoster virus. NEJM. 2005; 352: 2266-7.
• 7. Thomas SL. and Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004; 4: 26-33.
• 8. Vrcek I., Choudhury E. and Durairaj V. Herpes Zoster Ophthalmicus: A Review for the Internist. Am J Med. 2017;130(1):21–26.
• 9.Sjaastad O. et al. Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia 1989; 9:147–156.
• 10. Akpinar ÇK. ve ark. Herpes Zoster Ophthalmicus That Mimics the SUNCT Syndrome. Noro Psikiyatr Ars. 2016; 53(2):184-185.
• 11. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002 Aug 1;347(5):340-6. doi: 10.1056/NEJMcp013211. PMID: 12151472.
• 12. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341. Erratum in: Mayo Clin Proc. 2008 Feb;83(2):255. PMID: 17976353.
• 13. Straus SE, Ostrove JM, Inchauspé G, Felser JM, Freifeld A, Croen KD, Sawyer MH. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med. 1988 Feb;108(2):221-37. doi: 10.7326/0003-4819-108-2-221. Erratum in: Ann Intern Med 1988 Sep 1;109(5):438-9. PMID: 2829675.
• 14. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997 Jun 9;157(11):1209-13. PMID: 9183232.
• 15. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002 Oct 15;186 Suppl 1:S91-8. doi: 10.1086/342963. PMID: 12353193.
• 16. Çeviker, S. A., Günal, Ö., KILIÇ, S. S., Köksal, E., & Aygün, C. İmmunkompetan yaşlı hastada gelişen herpes zoster oftalmikus: Olgu sunumu. Batı Karadeniz Tıp Dergisi 2019. i, 3(2), 61-65.
• 17. Werner RN, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20-29.